3prime RNA-seq of human prostate cancer cell line DU-145 treated with Senexin A

ABSTRACT: Human prostate cancer cell line DU-145 was treated with Senexin A or DMSO control for 48h before performing 3-prime RNAseq.

INSTRUMENT(S): Illumina HiSeq 2500

ORGANISM(S): Homo sapiens

SUBMITTER: Johannes Braegelmann 

PROVIDER: E-MTAB-5150 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress